Circulation Research

From WikiMD's WELLNESSPEDIA

Circulation Research is a biweekly peer-reviewed medical journal that publishes articles related to the field of cardiovascular biology and medicine. The journal was established in 1953 and is currently published by the American Heart Association. The editor-in-chief is Roberto Bolli (University of Louisville).

Overview[edit]

Circulation Research focuses on publishing high-quality, innovative research in the realm of cardiovascular biology and medicine. The journal covers a broad spectrum of topics, including but not limited to, molecular biology, cell biology, pharmacology, genetics, genomics, and epigenetics related to cardiovascular health and disease.

Content[edit]

The journal publishes a variety of content types, including original research articles, review articles, and editorials. The original research articles are comprehensive reports of significant findings in cardiovascular biology and medicine. Review articles provide a synthesis of existing literature on a specific topic, while editorials offer expert commentary on the latest research findings.

Impact[edit]

Circulation Research is considered one of the leading journals in the field of cardiovascular research. According to the Journal Citation Reports, the journal has an impact factor of 15.211, ranking it 1st out of 126 journals in the category "Peripheral Vascular Disease."

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.